» Articles » PMID: 35250938

Consistent Biofilm Formation by Isolated From Patients With Necrotizing Soft Tissue Infections

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Mar 7
PMID 35250938
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Biofilm formation has been demonstrated in muscle and soft tissue samples from patients with necrotizing soft tissue infection (NSTI) caused by , but the clinical importance of this observation is not clear. Although M-protein has been shown to be important for biofilm formation in , the evidence for an association between type and biofilm forming capacity is conflicting. Here we characterize the biofilm forming capacity in a collection of isolates causing NSTI, and relate this to type of the isolates and clinical characteristics of the patients.

Methods: Bacterial isolates and clinical data were obtained from NSTI patients enrolled in a multicenter prospective observational study. Biofilm forming capacity was determined using a microtiter plate assay.

Results: Among 57 cases, the three most frequently encountered types were ( = 22), ( = 13), and ( = 7). The distribution of biofilm forming capacity in was qualitatively (narrow-ranged normal distribution) and quantitatively (21/22 isolates in the intermediate range) different from other types (wide ranged, multimodal distribution with 5/35 isolates in the same range as ). There were no significant associations between biofilm forming capacity and clinical characteristics of the patients.

Conclusions: The biofilm forming capacity of isolates was uniform and differed significantly from other types. The impact of biofilm formation in NSTI caused by on clinical outcomes remains uncertain.

Citing Articles

Streptokinase reduces Streptococcus dysgalactiae subsp. equisimilis biofilm formation.

Tolken L, Neufend J, Oppegaard O, Methling K, Moll K, Redanz S BMC Microbiol. 2024; 24(1):378.

PMID: 39350011 PMC: 11440690. DOI: 10.1186/s12866-024-03540-w.


Cutaneous tuberculosis-ambiguous transmission, bacterial diversity with biofilm formation in humoral abnormality: case report illustration.

Zdziarski P, Pasciak M, Chudzik A, Kozinska M, Augustynowicz-Kopec E, Gamian A Front Public Health. 2023; 11:1091373.

PMID: 37213612 PMC: 10194659. DOI: 10.3389/fpubh.2023.1091373.


The Cell Wall Deacetylases Spy1094 and Spy1370 Contribute to Virulence.

Aspell T, Khemlani A, Tsai C, Loh J, Proft T Microorganisms. 2023; 11(2).

PMID: 36838272 PMC: 9966966. DOI: 10.3390/microorganisms11020305.

References
1.
Sartelli M, Guirao X, Hardcastle T, Kluger Y, Boermeester M, Rasa K . 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018; 13:58. PMC: 6295010. DOI: 10.1186/s13017-018-0219-9. View

2.
Cho K, Caparon M . Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol. 2005; 57(6):1545-56. DOI: 10.1111/j.1365-2958.2005.04786.x. View

3.
Lembke C, Podbielski A, Hidalgo-Grass C, Jonas L, Hanski E, Kreikemeyer B . Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol. 2006; 72(4):2864-75. PMC: 1449035. DOI: 10.1128/AEM.72.4.2864-2875.2006. View

4.
Bruun T, Rath E, Madsen M, Oppegaard O, Nekludov M, Arnell P . Risk Factors and Predictors of Mortality in Streptococcal Necrotizing Soft-tissue Infections: A Multicenter Prospective Study. Clin Infect Dis. 2020; 72(2):293-300. PMC: 7840107. DOI: 10.1093/cid/ciaa027. View

5.
Barnett T, Bowen A, Carapetis J . The fall and rise of Group A diseases. Epidemiol Infect. 2018; 147:e4. PMC: 6518539. DOI: 10.1017/S0950268818002285. View